Home › Compare › CHMMF vs DIVO

CHMMF vs DIVO: Dividend Comparison 2026

CHMMF yields 200000.00% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CHMMF wins by $4.911780474428384e+29M in total portfolio value
10 years
CHMMF
CHMMF
● Live price
200000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.911780474428384e+29M
Annual income
$490,695,411,370,591,700,000,000,000,000,000,000.00
Full CHMMF calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — CHMMF vs DIVO

📍 CHMMF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCHMMFDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CHMMF + DIVO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CHMMF pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHMMF
Annual income on $10K today (after 15% tax)
$17,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$417,091,099,665,002,940,000,000,000,000,000,000.00/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, CHMMF beats the other by $417,091,099,665,002,940,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHMMF + DIVO for your $10,000?

CHMMF: 50%DIVO: 50%
100% DIVO50/50100% CHMMF
Portfolio after 10yr
$2.455890237214192e+29M
Annual income
$245,347,705,685,295,860,000,000,000,000,000,000.00/yr
Blended yield
99.90%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHMMF buys
0
DIVO buys
0
No recent congressional trades found for CHMMF or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCHMMFDIVO
Forward yield200000.00% ✓6.49%
Annual dividend / share$2.00$2.91 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.911780474428384e+29M$30.7K ✓
Annual income after 10y$490,695,411,370,591,700,000,000,000,000,000,000.00 ✓$981.68
Total dividends collected$4.911464459982279e+29M$8.2K ✓
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: CHMMF vs DIVO ($10,000, DRIP)

YearCHMMF PortfolioCHMMF Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$20,010,700$20,000,000.00$11,349$649.42+$20.00M → CHMMF
2$37,424,589,019$37,403,177,570.09$12,833$688.83+$37424.58M → CHMMF
3$65,416,215,188,220$65,376,170,877,969.18$14,459$727.90+$65416215.17M → CHMMF
4$106,868,230,495,008,900$106,798,235,144,757,520.00$16,238$766.49+$106868230494.99M → CHMMF
5$163,172,871,735,896,870,000$163,058,522,729,267,200,000.00$18,179$804.47+$163172871735896.84M → CHMMF
6$232,854,599,801,468,860,000,000$232,680,004,828,711,460,000,000.00$20,293$841.71+$232854599801468864.00M → CHMMF
7$310,570,858,137,017,100,000,000,000$310,321,703,715,229,540,000,000,000.00$22,591$878.14+$310570858137017057280.00M → CHMMF
8$387,148,154,301,613,200,000,000,000,000$386,815,843,483,406,600,000,000,000,000.00$25,087$913.65+$3.871481543016132e+23M → CHMMF
9$451,061,749,763,281,040,000,000,000,000,000$450,647,501,238,178,360,000,000,000,000,000.00$27,791$948.18+$4.510617497632811e+26M → CHMMF
10$491,178,047,442,838,440,000,000,000,000,000,000$490,695,411,370,591,700,000,000,000,000,000,000.00$30,718$981.68+$4.911780474428384e+29M → CHMMF

CHMMF vs DIVO: Complete Analysis 2026

CHMMF — Stock

Chimeric Therapeutics Limited, a clinical stage cell therapy company, develops and commercializes a range of cell therapies in oncology in Australia. The company develops CHM 0201 (core NK platform) that is in phase I clinical trial for treating solid tumors and hematological malignancies; and CHM 1101 (CLTX CAR T), which is in phase I clinical trial for treating patients with MMP2+ recurrent or progressive glioblastoma. It is also developing CHM 0301 for blood cancers; CHM 1301 (CLTX CAR NK) and CHM 2301 (CDH17 CAR NK) for solid tumors; CHM 1101 (CLTX CAR T) for melanoma, colorectal, and prostate; and CHM 2101 (CDH17 CAR T) for neuroendocrine, colorectal, pancreatic, and gastric. The company was incorporated in 2020 and is based in Carlton, Australia.

Full CHMMF Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this CHMMF vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHMMF vs SCHDCHMMF vs JEPICHMMF vs OCHMMF vs KOCHMMF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.